📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 17:44
538 analysed today
FollowTelegram
538
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
2 announcements match the current filters (relevance ≥ 5).
Rs 12.3 Lacs PAT: Rajnish Wellness Returns to Profitability Despite 70% QoQ Revenue Drop
Rajnish Wellness reported a standalone net profit of Rs 12.30 Lacs for Q1 FY27, recovering from a significant loss of Rs 4.70 Cr in the preceding quarter. Revenue from operations stood at Rs 31.01 Cr, which is a sharp 69.6% decline from the Rs 101.95 Cr reported in Q4 FY26, though it remains up 580% YoY. The company's business model remains characterized by extremely thin margins, with stock-in-trade purchases (Rs 30.30 Cr) accounting for 97.7% of revenue. Total expenses for the quarter were Rs 30.97 Cr, resulting in a marginal profit before tax of Rs 12.30 Lacs.
Confidence: HIGH
What changedThe company has returned to a marginal profit after a heavy loss in the previous quarter, although revenue has contracted significantly on a sequential basis.
Why it mattersFor a micro-cap company with a market capitalization below its book value and share capital, achieving consistent profitability is critical to prevent further capital erosion.
Revenue (Q1 FY27): Rs 31.01 CrNet Profit (Q1 FY27): Rs 0.123 CrQoQ Revenue Growth: -69.6%YoY Revenue Growth: +580%Stock-in-trade to Revenue: 97.7%PBT Margin: 0.4%
📅 Short termThe return to profitability may provide a minor sentiment boost, but the massive sequential revenue drop and thin margins are likely to keep the stock under pressure.
📈 Long termThe business model appears to be high-volume, low-margin trading; long-term value creation will require a shift toward higher-margin pharmaceutical products or services.
⚠ Risk flags
- Extreme revenue volatility between quarters
- Very thin operating margins (sub-1%)
- Low promoter holding at 9.2%
- Penny stock status with high price volatility
Key Highlights
Net Profit of Rs 12.30 Lacs in Q1 FY27 vs a loss of Rs 4.70 Cr in Q4 FY26
Revenue from operations fell 69.6% QoQ to Rs 31.01 Cr from Rs 101.95 Cr
Purchases of stock-in-trade at Rs 30.30 Cr represent 97.7% of total revenue
Paid-up equity share capital stands at Rs 101.53 Cr, significantly higher than the current market cap of Rs 36 Cr
Earnings Per Share (EPS) improved to Rs 0.0012 from a negative Rs 0.05 in the previous quarter
👀 What to Watch
Investors should monitor the company's ability to stabilize its revenue base and improve operating margins, which currently stand at a very thin 0.4% at the PBT level.
Rajnish Wellness Q1 Results: Net Profit of ₹0.12 Cr; Revenue Drops 69% QoQ to ₹31.01 Cr
Rajnish Wellness reported a return to profitability in Q1 FY27 with a net profit of ₹0.12 Cr, recovering from a loss of ₹4.70 Cr in the previous quarter. However, revenue saw a sharp sequential decline of 69.6%, falling to ₹31.01 Cr from ₹101.95 Cr in Q4 FY26. While YoY revenue growth appears high (up from ₹4.56 Cr), the business remains characterized by razor-thin margins, with stock-in-trade purchases consuming 97.7% of revenue. The company's market cap remains small at ₹36 Cr with a low promoter holding of 9.2%.
Confidence: HIGH
What changedThe company has returned to a marginal profit after a significant loss in the previous quarter, though on a much smaller revenue base.
Why it mattersThe extreme fluctuations in revenue (from ₹4.5 Cr to ₹101 Cr to ₹31 Cr over three quarters) indicate an inconsistent business cycle or opportunistic trading, which makes long-term valuation difficult for a micro-cap firm.
Revenue (Q1 FY27): ₹31.01 CrNet Profit (Q1 FY27): ₹0.12 CrQoQ Revenue Growth: -69.6%Stock-in-trade as % of Revenue: 97.7%Promoter Holding: 9.16%
📅 Short termThe return to profitability may provide a minor sentiment boost, but the massive sequential revenue drop is likely to temper any significant rally.
📈 Long termStructural significance is limited due to the low-margin nature of the business and high revenue volatility; consistent performance over multiple quarters is required to build investor confidence.
⚠ Risk flags
- High revenue volatility
- Razor-thin operating margins (0.4% PBT margin)
- Low promoter holding (9.2%)
- Penny stock risks (Price < ₹1)
Key Highlights
Revenue from operations stood at ₹31.01 Cr for the quarter ended June 30, 2026.
Net profit turned positive at ₹12.30 Lacs (₹0.12 Cr) versus a loss of ₹4.70 Cr in the preceding quarter.
Sequential revenue declined by 69.6% from ₹101.95 Cr in the March 2026 quarter.
Purchases of stock-in-trade accounted for ₹30.30 Cr, representing nearly the entire operating cost base.
Earnings per share (EPS) for the quarter was reported at ₹0.0012.
👀 What to Watch
Investors should monitor the extreme volatility in quarterly revenue and the sustainability of the current low-margin trading model. The high reliance on 'Stock-in-Trade' purchases suggests a distribution-heavy business with limited manufacturing value-add.
